IDEV Technologies Retains Hatch Medical to Divest Product Lines.DULUTH, Ga. -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has been retained by IDEV IDEV International Development Technologies, Inc. to exclusively broker the sale of its FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. cleared and CE Marked product lines, the Texan(R) LONGhorn The code name for the Windows Vista operating system. After the client version was renamed "Vista" in 2005, Longhorn referred to the server version until it was officially named Windows Server 2008 in May of 2007. See Windows Vista. and mini-Tex(TM) foreign body retrieval devices and the AKonya Eliminator(TM) and AKonya Eliminator Plus(TM) mechanical thrombectomy thrombectomy /throm·bec·to·my/ (throm-bek´tah-me) surgical removal of a clot from a blood vessel. throm·bec·to·my n. Excision of a thrombus. devices. Paul Gianneschi, Managing Principal at Hatch Medical commented, "We are excited to be partnering with IDEV Technologies on this assignment and look forward to successfully brokering the acquisition or license of IDEV's unique technologies; no doubt complimentary to any endovascular product line." Thomas Tully, IDEV's Chairman and Chief Executive Officer added, "We are very pleased to have the expertise of Hatch Medical on our side as we work through the divestiture The breakup of AT&T. By federal court order, AT&T divested itself on January 1, 1984 of its 23 operating companies, which became known as the Regional Bell Operating Companies (RBOCs). of these product lines. Divesting these businesses allows our team to focus on our emerging stent business, which we believe has unmatched potential." IDEV Technologies, Inc. is an innovator and emerging leader in peripheral stent technologies. IDEV is based in Houston, Texas “Houston” redirects here. For other uses, see Houston (disambiguation). Houston (pronounced /'hjuːstən/) is the largest city in the state of Texas and the and its current portfolio contains over thirty technologies exclusively licensed from the M.D. Anderson Cancer Center, representing over a $5.0 billion dollar market opportunity worldwide. For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at info@hatchmedical.com, or call 770-476-9940. This release and additional news about Hatch Medical can be obtained by visiting the company's web site at: http://www.hatchmedical.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion